SMMT
Summit Therapeutics PLC
15.60$
-4.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | |
| 0.0% | 4.0% | 2.6% | 0.7% | 0.0% | 0.5% | – | – | 431.1% | – | – | – | |
| 100.0% | 100.0% | 100.0% | 100.0% | 98.8% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | |
| 551.7% | 1,315.8% | 797.6% | 204.5% | 86.0% | 91.1% | 6,194.7% | 4,718.2% | 7,375.7% | – | – | – | |
| 196.2% | 362.2% | 348.4% | 84.2% | 28.4% | 21.6% | 2,236.3% | 1,305.2% | 3,793.3% | – | – | – | |
| 747.9% | 1,688.3% | 1,146.0% | 282.3% | 90.5% | -91.1% | 6,285.2% | 4,864.3% | 10,325.4% | – | – | – | |
| -647.9% | -1,588.3% | -1,046.0% | -182.3% | 9.4% | 35.2% | -11,392.7% | -4,764.3% | -10,225.4% | – | – | – | |
| 23.7% | 27.4% | 45.3% | 11.6% | 1.1% | 0.1% | 40.5% | 15.5% | 754.6% | – | – | – | |
| -671.7% | -1,810.7% | -1,081.9% | -168.8% | 15.9% | 11.6% | -9,902.3% | -4,897.8% | -11,174.8% | – | – | – | |
| -76.7% | -257.1% | -228.1% | -24.5% | -3.1% | -8.9% | -1,522.7% | -135.7% | -775.6% | – | – | – | |
| -603.0% | -1,572.0% | -899.5% | -142.3% | 19.0% | 11.6% | -6,127.6% | -4,762.1% | -11,174.8% | – | – | – | |
| -646.2% | -1,584.5% | -1,043.6% | -185.9% | 20.4% | 36.5% | -5,904.9% | -4,628.6% | -8,845.1% | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.